The effect of edrophonium on erythrocyte acetylcholinesterase and neuromuscular function in the rat
- PMID: 175874
- PMCID: PMC1666764
- DOI: 10.1111/j.1476-5381.1976.tb06963.x
The effect of edrophonium on erythrocyte acetylcholinesterase and neuromuscular function in the rat
Abstract
1. The relation between the concentration of edrophonium in plasma, inhibition of red cell acetylcholinesterase, and neuromuscular transmission was studied in the rat. 2. In both in vivo and in vitro conditions, red cell acetylcholinesterase activity was predictably related to the concentration of the quaternary amine. 3. After low doses of edrophonium (1.0 mumol/kg) there was a significant correlation between the monophasic potentiation of twitch tension and the plasma concentration of the drug. In contrast, with higher doses of edrophonium (4.0 or 10.0 mumol/kg) a biphasic potentiation of twitch tension was observed; this was only correlated with the plasma concentration of the drug during the secondary decline in neuromuscular facilitation. Subsequent recovery of normal neuromuscular transmission invariably occurred at a constant plasma concentration of edrophonium.
Similar articles
-
Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.J Pharmacokinet Biopharm. 1996 Aug;24(4):327-48. doi: 10.1007/BF02353516. J Pharmacokinet Biopharm. 1996. PMID: 9044164
-
The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium.Br J Pharmacol. 1979 Aug;66(4):525-30. doi: 10.1111/j.1476-5381.1979.tb13690.x. Br J Pharmacol. 1979. PMID: 223706 Free PMC article.
-
Proceedings: The relation between the plasma concentration of edrophonium, inhibition of erythrocyte acetylcholinesterase, and the facilitation of neuromuscular function in the rat.Br J Pharmacol. 1975 Jun;54(2):263P-264P. Br J Pharmacol. 1975. PMID: 1148545 Free PMC article. No abstract available.
-
[Therapy of myasthenia gravis with cholinesterase inhibitors--principles and pharmacologic monitoring].Fortschr Neurol Psychiatr. 1996 Mar;64(3):110-21. doi: 10.1055/s-2007-996377. Fortschr Neurol Psychiatr. 1996. PMID: 8900891 Review. German.
-
Edrophonium.2025 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2025 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999829 Free Books & Documents. Review.
Cited by
-
Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.J Pharmacokinet Biopharm. 1996 Aug;24(4):327-48. doi: 10.1007/BF02353516. J Pharmacokinet Biopharm. 1996. PMID: 9044164
-
The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium.Br J Pharmacol. 1979 Aug;66(4):525-30. doi: 10.1111/j.1476-5381.1979.tb13690.x. Br J Pharmacol. 1979. PMID: 223706 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources